ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 180 filers reported holding ARIAD PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $586,000 | -9.1% | 47,100 | 0.0% | 0.10% | -8.3% |
| Q3 2016 | $645,000 | +85.3% | 47,100 | 0.0% | 0.11% | +77.0% |
| Q2 2016 | $348,000 | +15.6% | 47,100 | 0.0% | 0.06% | +8.9% |
| Q1 2016 | $301,000 | +15.3% | 47,100 | +12.7% | 0.06% | +9.8% |
| Q4 2015 | $261,000 | -65.1% | 41,800 | -67.4% | 0.05% | -65.5% |
| Q3 2015 | $748,000 | +73.1% | 128,181 | +145.2% | 0.15% | +80.5% |
| Q2 2015 | $432,000 | – | 52,275 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $69,390,000 | 26.80% |
| Opaleye Management Inc. | 1,500,000 | $8,100,000,000 | 6.31% |
| Camber Capital Management LP | 6,000,000 | $32,400,000 | 3.04% |
| Ghost Tree Capital, LLC | 700,000 | $3,780,000 | 2.05% |
| Granite Point Capital Management, L.P. | 700,000 | $3,780,000 | 1.88% |
| Duquesne Family Office | 1,645,000 | $8,883,000 | 1.09% |
| Geduld E E | 272,200 | $1,470,000 | 1.04% |
| Elk Creek Partners, LLC | 659,232 | $3,560,000 | 0.93% |
| Palo Alto Investors LP | 2,231,717 | $12,051,000 | 0.90% |
| HighVista Strategies LLC | 1,200,000 | $6,480,000 | 0.87% |